TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma.

Jiayong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.